Reproducibility problems with the Abbott laboratories LCx assay for Chlamydia trachomatis and Neisseria gonorrhoeae.
- 1 June 2000
- journal article
- clinical trial
- Vol. 38 (6) , 2416-8
Abstract
This study demonstrates that significant reproducibility problems can occur during routine use of the Abbott Laboratories LCx assay for Chlamydia trachomatis and Neisseria gonorrhoeae. These problems can go undetected by the quality control procedures outlined in the manufacturer's package insert. We outline here procedures for detecting and preventing contamination and reproducibility problems.This publication has 9 references indexed in Scilit:
- Urine Specimens from Pregnant and Nonpregnant Women Inhibitory to Amplification of Chlamydia trachomatis Nucleic Acid by PCR, Ligase Chain Reaction, and Transcription-Mediated Amplification: Identification of Urinary Substances Associated with Inhibition and Removal of Inhibitory ActivityJournal of Clinical Microbiology, 1998
- Reproducibility of the Roche Amplicor Polymerase Chain Reaction Assay for Detection of Infection by Chlamydia trachomatis in Endocervical SpecimensClinical Chemistry, 1998
- False-negative results of a ligase chain reaction assay to detectChlamydia trachomatis due to inhibitors in urineEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Urinary inhibitors of polymerase chain reaction and ligase chain reaction and testing of multiple specimens may contribute to lower assay sensitivities for diagnosingChlamydia trachomatisinfected womenMolecular and Cellular Probes, 1997
- Comparison of ligase chain reaction and culture for detection of Neisseria gonorrhoeae in genital and extragenital specimensJournal of Clinical Microbiology, 1997